Relationship between Diabetes Duration and Real-World Effectiveness of Second-Line Dual OAD Therapy

被引：0
|
作者：
Brath, Helmut
Paldanius, Paeivi M.
Bader, Giovanni
Mathieu, Chantal
机构：
来源：
DIABETES | 2015年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1220-P
引用
收藏
页码：A315 / A316
页数：2
相关论文
共 50 条
  • [1] Second-Line Therapy for Immune Thrombocytopenia: Real-World Experience
    Nazaryan, Hasmik
    Liu, Yang
    Sirotich, Emily
    Duncan, Joanne M.
    Arnold, Donald M.
    BLOOD, 2019, 134
  • [2] The real-world effectiveness of intravenous brivaracetam as a second-line treatment in status epilepticus
    Martellino, Chiara
    Lagana, Angelina
    Atanasio, Giorgia
    Lamanna, Fabio
    Attardo, Silvia
    Cascino, Simona
    De Luca, Marcella
    Pardeo, Orazio
    Giacobbe, Giuseppa
    Tripepi, Giovanni
    Roberti, Roberta
    Granata, Francesca
    Morace, Carmela
    Russo, Emilio
    Labate, Angelo
    EPILEPSY & BEHAVIOR, 2023, 148
  • [3] Real-world Positioning and Effectiveness of First- and Second-Line Biological Therapy in Inflammatory Bowel Diseases
    Reves, Joana
    Torres, Joana
    JOURNAL OF CROHNS & COLITIS, 2024, 18 (06): : 787 - 789
  • [4] UPTAKE OF NEWER SECOND-LINE DIABETES MEDICATIONS IN REAL-WORLD VULNERABLE POPULATIONS
    Ogunsanmi, D.
    Harrison, A. T.
    Kovesdy, C. P.
    Surbhi, S.
    VALUE IN HEALTH, 2022, 25 (07) : S499 - S499
  • [5] Real-World Effectiveness of Gliclazide MR vs. Sitagliptin as Second-Line Therapy in People with Type 2 Diabetes Uncontrolled on Metformin
    Zaccardi, Francesco
    Cortese, Viviana
    Jacquot, Emmanuelle
    Tyrer, Freya
    Seidu, Samuel
    Davies, Melanie J.
    Khunti, Kamlesh
    DIABETES, 2020, 69
  • [6] EFFECTIVENESS AND SAFETY OF SECOND-LINE THERAPY IN PRIMARY BILIARY CHOLANGITIS (PBC): A PROSPECTIVE MULTICENTER REAL-WORLD COHORT
    Gomez-Dominguez, Elena
    Montero, Jose-Luis
    Molina, Esther
    Casado, Marta
    Garcia-Buey, Maria Luisa
    Simon, Miguel Angel
    Fuentes, Javier
    Diaz-Gonzalez, Alvaro
    Berenguer, Marina
    Conde, Isabel
    Garrido, Isabel
    Macedo, Guilherme
    Jorquera, Francisco
    Morillas, Rosa Maria
    Presa, Jose Antonio
    Rodriguez-Tajes, Sergio
    Olivas, Ignasi
    Londono, Maria Carlota
    Ampuero, Javier
    Romero-Gonzalez, Eva
    Gonzalez-Padilla, Sheila
    Escudero-Garcia, Desamparados
    Martin, Jose Manuel Sousa
    Gomes, Dario Lorga
    Santos, Luis
    Olveria, Antonio
    Hernandez-Guerra, Manuel
    Santos, Manuel A.
    Carvalho, Armando S. P.
    Uriz, Juan
    Gutierrez, Maria Luisa
    Quinones, Marta
    Perez, Elia
    Martinez, Javier
    Albillos, Agustin
    Fernandez-Rodriguez, Conrado
    HEPATOLOGY, 2023, 78 : S116 - S117
  • [7] Real-World Survival Outcomes of Patients with Malignant Pleural Mesothelioma by Choice of Second-line Therapy
    Kerrigan, K.
    Chipman, J.
    Jo, Y. J.
    Haaland, B.
    Johnson, E.
    Puri, S.
    Varghese, T.
    Akerley, W.
    Patel, S.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S199 - S199
  • [8] Real-World Effectiveness of Second-Line Therapies for Metastatic Non-Small Cell Lung Cancer
    Bazhenova, L.
    Cai, B.
    Gentile, D.
    Kari, G.
    Feinberg, B.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (03) : E22 - E22
  • [9] A real-world effectiveness of second-line osimertinib in NSCLC patients: A multi-institutions study in Taiwan
    Chen, Hui-Yu
    Chang, Kaicheng
    Shao, Shih-Chieh
    Fang, Yueh-Fu
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 343 - 343
  • [10] EFfectiveness and Safety Profile of Lurbinectedin in Second-Line Small Cell Lung Cancer: A Real-World Study
    Ganti, A. K.
    Allan, V.
    Merola, D.
    Estrin, A.
    Boccuti, A.
    Rengarajan, B.
    Baratta, C.
    Prince, P.
    Li, W.
    Cao, Y.
    D'Agostino, R. B., Jr.
    Poole, E. M.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S378 - S379
12345